Zhihao Han Selected Research

Zhihao Han Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 01/2016
4	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 12/2018
2	Inflammation (Inflammations) 04/2024 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2023
2	Carcinoma (Carcinomatosis) 11/2023 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 05/2020
1	Lymphoma (Lymphomas) 04/2024
1	Leukemia 04/2024
1	Starvation 12/2023
1	Necrosis 11/2023
1	Colitis 11/2023
1	Adenoma (Adenomas) 11/2023
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2020
1	Rupture 11/2020
1	Cardiotoxicity 01/2016

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 02/2024 - 01/2017
5	Radioisotopes (Radionuclides)IBA 01/2023 - 05/2020
4	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2018
3	Bombesin Receptors (Bombesin Receptor)IBA 01/2023 - 05/2020
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2019
2	LigandsIBA 08/2022 - 12/2020
2	IntegrinsIBA 11/2020 - 01/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2019 - 08/2018
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2019 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 02/2019 - 09/2017
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 03/2016
1	Chimeric Antigen ReceptorsIBA 04/2024
1	Indicators and Reagents (Reagents)IBA 02/2024
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023
1	Erythropoietin FDA Link 12/2023
1	EphA2 ReceptorIBA 12/2023
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 12/2023
1	GlycogenIBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	LipidsIBA 12/2023
1	Liver GlycogenIBA 12/2023
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2023
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2023
1	PhosphoenolpyruvateIBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Ribosomal Protein S6IBA 12/2023
1	Sirolimus (Rapamycin)FDA Link 12/2023
1	Pyruvate KinaseIBA 12/2023
1	TransferasesIBA 12/2023
1	Acetyl-CoA CarboxylaseIBA 12/2023
1	Insulin-Like PeptidesIBA 12/2023
1	PhosphofructokinasesIBA 12/2023
1	GlucokinaseIBA 12/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2023
1	EP4 Subtype Prostaglandin E ReceptorsIBA 11/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2023
1	SaltsIBA 01/2023
1	Cytostatic AgentsIBA 08/2022
1	Angiotensin IIIBA 12/2020
1	BombesinIBA 12/2020
1	Coloring Agents (Dyes)IBA 05/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2019
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 02/2019
1	RNA IIBA 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 01/2019
1	Nucleotide AptamersIBA 01/2019
1	GlypicansIBA 12/2018
1	neodymium pyrocatechin disulfonate (NPD)IBA 08/2018
1	ProdrugsIBA 08/2018
1	Cytidine Monophosphate (CMP)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	CypateIBA 12/2017
1	Liposomes (Liposome)IBA 12/2017
1	Therapeutic UsesIBA 09/2017
1	ChitosanIBA 09/2017
1	Drug CarriersIBA 09/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	GoldIBA 03/2016
1	liposomal doxorubicin (Doxil)FDA Link 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 01/2016

Therapy/Procedure

6	Therapeutics 12/2023 - 01/2017
3	Drug Therapy (Chemotherapy) 02/2019 - 03/2016
3	Precision Medicine 08/2018 - 03/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024
1	Computer-Assisted Surgery (Image Guided Surgery) 02/2024
1	Laparotomy 11/2023
1	Molecular Targeted Therapy 01/2023
1	Quantum Dots (Quantum Dot) 08/2018
1	Photochemotherapy (Photodynamic Therapy) 01/2016